دانلود مقالات ISI درباره نرخ کنترل بیماری + ترجمه فارسی

تزریق می تواند عاید را بهبود بقا عمومی در بیماران مبتلا به سرطان ریه های غیر سلولی یک بررسی سیستماتیک و متاآنالیز 25 آزمایش تصادفی کنترل شده

Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials

Keywords: نرخ کنترل بیماری; BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co

دانلود رایگان متن کامل مقاله ISI 11 صفحه سال انتشار : 2018 سفارش ترجمه

عدم توزیع فرصت های دارویی و مسیرهای آینده درمان های هدفمند در سرطان های دستگاه گوارش قسمت 2: تومورهای نوروئیدوکرین، کارسینوم سلول های خونی و تومورهای استرومای روده ای

Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours

Keywords: نرخ کنترل بیماری; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP

دانلود رایگان متن کامل مقاله ISI 27 صفحه سال انتشار : 2018 سفارش ترجمه

اثربخشی و ایمنی ایربولین به عنوان اولین درمان در بیماران مبتلا به سرطان پستان پیشرفته یا متاستاتیک که قبلا توسط آنتراسیکلین و مالیون درمان شده بود

Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes

Keywords: نرخ کنترل بیماری; Eribulin; Metastatic breast cancer; First-line; Microtubule; Dose-intensity; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; DCR; disease control rate; DOR; duration of response; ECOG PS; Eas

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2017 سفارش ترجمه

تحمل پذیری و اثربخشی آپاتینیب در دوز پایین شروع در 10 بیمار مبتلا به بیماری سالم یا پایین عملکرد با سرطان ریه مقاوم به درمان غیر سلولی کوچک

Tolerability and efficacy of afatinib at a low starting dosage in 10 elderly or low performance status patients with advanced refractory non-small-cell lung cancer

Keywords: نرخ کنترل بیماری; DCR; disease control rate; D-ILD; drug-induced interstitial lung disease; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; NSCLC; non-small-cell lung cancer; ORR; objective response rate; OS; overall survival; PD; progressive disease,

دانلود رایگان متن کامل مقاله ISI 5 صفحه سال انتشار : 2016 سفارش ترجمه

Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines

Keywords: نرخ کنترل بیماری; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f

دانلود رایگان متن کامل مقاله ISI 32 صفحه سال انتشار : 2019 سفارش ترجمه

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease

Keywords: نرخ کنترل بیماری; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2018 سفارش ترجمه

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer

Keywords: نرخ کنترل بیماری; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2018 سفارش ترجمه

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

Keywords: نرخ کنترل بیماری; AE; adverse event; ALK; anaplastic lymphoma kinase; CR; complete response; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group Performance Status; EGFR; epidermal growth factor receptor; HR; hazard ratio; irAE; immune related adverse ev

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2018 سفارش ترجمه

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

Keywords: نرخ کنترل بیماری; CI; confidence interval; DCR; disease control rate; DOC; docetaxel; EMA; European Medicines Agency; FDA; US Food and Drug Administration; HR; hazard ratio; ITT; intent to treat; NSCLC; non-small cell lung cancer; OR; odds ratio; ORR; objective response ra

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2018 سفارش ترجمه

Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives

Keywords: نرخ کنترل بیماری; NNSCLC; non-small cell lung cancer; OS; overall survival; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; ALK; Anaplastic lymphoma kinase; MET; mesenchymal epithelial transition factor; PFS; progression free survival; HER2; human e

دانلود رایگان متن کامل مقاله ISI 13 صفحه سال انتشار : 2018 سفارش ترجمه

Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial

Keywords: نرخ کنترل بیماری; CM; complementary medicine; CT; computerized tomography; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EMA; European Medicines Agency; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Q

دانلود رایگان متن کامل مقاله ISI 29 صفحه سال انتشار : 2018 سفارش ترجمه

CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin

Keywords: نرخ کنترل بیماری; CI; ConfidenceInterval; CT; ComputedTomography; CTTA; CT-TexturalAnalysis; DCR; Disease Control Rate; DNA; DeoxyribonucleicAcid; FDG-PET; Fludeoxyglucose-Positron Emission Tomography; Fig.; Figure; GIST; Gastrointestinal Stromal Tumor; NGLD; MNeighboring

دانلود رایگان متن کامل مقاله ISI 33 صفحه سال انتشار : 2018 سفارش ترجمه

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer

Keywords: نرخ کنترل بیماری; BID; twice daily; CARBO-ETOP; carboplatin-etoposide therapy; CDK; cyclin-dependent kinase; CI; confidence interval; CIS-ETOP; cisplatin-etoposide therapy; DCR; disease control rate; DLT; dose-limiting toxicity; DoR; duration of response; ED-SCLC; extensiv

دانلود رایگان متن کامل مقاله ISI 36 صفحه سال انتشار : 2018 سفارش ترجمه

Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines

Keywords: نرخ کنترل بیماری; NSCLC; non-small cell lung cancer; PBC; platinum-based chemotherapy; CR; complete response; PR; partial response; NC; no change; SD; stable disease; PD; progressive disease; ORR; objective response rate; DCR; Disease Control Rate; KPS; karnofsky performan

دانلود رایگان متن کامل مقاله ISI 39 صفحه سال انتشار : 2018 سفارش ترجمه

Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study

Keywords: نرخ کنترل بیماری; AE; adverse event; CI; confidence interval; DBS; dried blood spot; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EGFR; epidermal growth factor receptor; HER; human epidermal growth factor receptor; HR; hazard r

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2017 سفارش ترجمه

PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review

Keywords: نرخ کنترل بیماری; ALK; anaplastic lymphoma kinase; CI; confidence interval; ECOG; The Eastern Cooperative Oncology Group; DCB; durable clinical benefit; DCR; disease control rate; EGFR; epidermal growth factor receptor; EGFRm+; EGFR mutation positive; FDA; Food and Drug Ad

دانلود رایگان متن کامل مقاله ISI 16 صفحه سال انتشار : 2017 سفارش ترجمه

A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy

Keywords: نرخ کنترل بیماری; AE; adverse event; CI; confidence interval; CR; complete response; CT; computed tomography; DCR; disease control rate; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; FAS; full analysis set; HR; hazard ratio; ILD; interst

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2016 سفارش ترجمه

Original StudyDisease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database

Keywords: نرخ کنترل بیماری; Clinical trials; Disease control rate; Landmark analysis; Outcomes; Small-cell lung cancer; Targeted therapy; Tumor assessment;

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2016 سفارش ترجمه

Analysis of Response-Related and Time-to-event Endpoints in Randomized Trials of Gemcitabine-Based Treatment Versus Gemcitabine Alone as First-Line Treatment of Patients With Advanced Pancreatic Cancer

Keywords: نرخ کنترل بیماری; Chemotherapy; Disease control rate; Overall response rate; Pancreatic cancer; Progression-free survival;

دانلود رایگان متن کامل مقاله ISI 13 صفحه سال انتشار : 2016 سفارش ترجمه

Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test

Keywords: نرخ کنترل بیماری; Clinical trial design; Precision Cancer Medicine; Targeted therapy; CSC; Cancer stem cell; COSMIC; Catalogue of Somatic Mutations in Cancer; CTC; Circulating tumor cell; ctDNA; Circulating tumor DNA; CRC; Colorectal cancer; DCR; Disease control rate; EMA;

دانلود رایگان متن کامل مقاله ISI 11 صفحه سال انتشار : 2015 سفارش ترجمه

Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer

Keywords: نرخ کنترل بیماری; HER; human epidermal growth factor receptor; NSCLC; non-small cell lung cancer; DLT; dose-limiting toxicity; MTD; maximum tolerated dose; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; RECIST; response evaluation criteria in solid t

دانلود رایگان متن کامل مقاله ISI 37 صفحه سال انتشار : 2015 سفارش ترجمه

Lens culinaris agglutinin-reactive α-fetoprotein decline after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma predicts survival

Keywords: نرخ کنترل بیماری; HCC; hepatocellular carcinoma; AFP; α-fetoprotein; AFP-L3; Lens culinaris agglutinin-reactive α-fetoprotein; LCA; Lens culinaris agglutinin; Con A; concanavalin A; TACE; transcatheter arterial chemoembolization; Lectin dual-label TRFIAs; lectin dual-lab

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2014 سفارش ترجمه

Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)

Keywords: نرخ کنترل بیماری; BRCA1; breast cancer susceptibility gene 1; CI; confidence interval; DCR; disease control rate; DNA; deoxyribonucleic acid; ERCC1; enzyme repair cross-complementation group 1; FasL; Fas ligand; HES; hematoxylin-eosin-saffron; IHC; immunohistochemistry

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2014 سفارش ترجمه

Cancer Concepts and Principles: Primer for the Interventional Oncologist-Part I

Keywords: نرخ کنترل بیماری; CR; complete response; DCR; disease control rate; EASL; European Association for the Study of the Liver; FDA; Food and Drug Administration; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria in Solid Tumors; NCCN; National Compr

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2013 سفارش ترجمه

Treatment of Hepatocellular Carcinoma Combining Sorafenib and Transarterial Locoregional Therapy: State of the Science

Keywords: نرخ کنترل بیماری; AASLD; American Association for the Study of Liver Diseases; AE; adverse event; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; CR; complete response; DCR; disease control rate; DEB; doxorubicin-eluting bead; ECOG; Eastern Cooperative Oncolo

دانلود رایگان متن کامل مقاله ISI 12 صفحه سال انتشار : 2013 سفارش ترجمه

Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer

Keywords: نرخ کنترل بیماری; Lung cancer; Progression-free survival; Overall survival; Surrogate endpoint; Disease control rate; Clinical research;

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2012 سفارش ترجمه

Research ArticleEfficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

Keywords: نرخ کنترل بیماری; Hepatocellular carcinoma; Sorafenib; Subset analyses; Overall survival; Time to progression; Disease control rate;

دانلود رایگان متن کامل مقاله ISI 9 صفحه سال انتشار : 2012 سفارش ترجمه

Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in 143 Phase III Trials

Keywords: نرخ کنترل بیماری; Lung cancer; Phase III trial; Objective response rate; Disease control rate; Survival

دانلود رایگان متن کامل مقاله ISI 6 صفحه سال انتشار : 2007 سفارش ترجمه